相关实验视频
Updated: Jan 11, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.6K
骨质疏松症和骨肉瘤之间的分子交叉:识别常见的诊断标记和治疗点
1Department of Orthopedics, Tianjin Medical University Baodi Hospital, Tianjin, China.
The journal of gene medicine
|November 14, 2025
概括
研究人员确定了CLTA,MSR1,MTF2和SMAD3作为骨质疏松症和骨髓瘤中常见的关键基因. 这些基因可以作为关键的生物标志物和骨疾病的治疗点.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 骨质疏松症和骨质肉瘤共享潜在的分子通路.
- 识别常见的枢纽基因对于理解疾病的发病过程至关重要.
- 这项研究重点是针对骨癌和代谢性骨病的新生物标志物和治疗点.
研究的目的:
- 识别和验证骨质疏松症和骨质肉瘤中常见的枢纽基因.
- 探索这些基因作为诊断生物标记物的潜力.
- 研究它们作为治疗骨相关疾病的治疗点的实用性.
主要方法:
- 使用公共数据集 (GSE13850,GSE16088,GSE12865) 进行差异基因表达分析.
- 使用生物信息学工具 (R,limma,STRING,Cytoscape) 确定了常见的差异表达基因 (DEGs) 和枢纽基因.
- 通过RT-qPCR验证了基因表达,并评估了基因淘汰 (CLTA,SMAD3) 对细胞行为的功能影响.
主要成果:
- 确定了CLTA,MSR1,MTF2和SMAD3作为重要的枢纽基因.
- 这些基因在骨髓瘤中表达高,与患者预后不佳相关.
- 抑制CLTA和SMAD3抑制了骨髓瘤细胞系中的细胞增殖,殖民地形成和迁移.
结论:
- 建议CLTA,MSR1,MTF2和SMAD3作为骨质疏松症和骨髓瘤的潜在生物标志物和治疗点.
- 需要进一步的研究来阐明它们的临床适用性.
- 这项研究为开发针对骨疾病的向治疗提供了基础.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K